These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 25965903)

  • 1. Microparticles: Bridging the Gap between Autoimmunity and Thrombosis.
    Niccolai E; Emmi G; Squatrito D; Silvestri E; Emmi L; Amedei A; Prisco D
    Semin Thromb Hemost; 2015 Jun; 41(4):413-22. PubMed ID: 25965903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are microparticles the missing link between thrombosis and autoimmune diseases? Involvement in selected rheumatologic diseases.
    Cunningham M; Marks N; Barnado A; Wirth JR; Gilkeson G; Markiewicz M
    Semin Thromb Hemost; 2014 Sep; 40(6):675-81. PubMed ID: 25173498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating microparticles in systemic Lupus Erythematosus.
    Nielsen CT
    Dan Med J; 2012 Nov; 59(11):B4548. PubMed ID: 23171755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulating thrombotic diathesis in hereditary thrombophilia and antiphospholipid antibody syndrome: a role for circulating microparticles?
    Campello E; Radu CM; Spiezia L; Simioni P
    Clin Chem Lab Med; 2017 Jun; 55(7):934-943. PubMed ID: 27816948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microparticles as autoantigens in systemic lupus erythematosus.
    Mobarrez F; Svenungsson E; Pisetsky DS
    Eur J Clin Invest; 2018 Dec; 48(12):e13010. PubMed ID: 30062774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of microparticles in the pathogenesis of rheumatoid arthritis and systemic lupus erythematosus.
    Dye JR; Ullal AJ; Pisetsky DS
    Scand J Immunol; 2013 Aug; 78(2):140-8. PubMed ID: 23672591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of cell death in the pathogenesis of autoimmune disease: HMGB1 and microparticles as intercellular mediators of inflammation.
    Ardoin SP; Pisetsky DS
    Mod Rheumatol; 2008; 18(4):319-26. PubMed ID: 18418695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of chronic inflammatory and immune processes by extracellular vesicles.
    Robbins PD; Dorronsoro A; Booker CN
    J Clin Invest; 2016 Apr; 126(4):1173-80. PubMed ID: 27035808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microparticles, thrombosis and cancer.
    Aharon A; Brenner B
    Best Pract Res Clin Haematol; 2009 Mar; 22(1):61-9. PubMed ID: 19285273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microparticles, malignancy and thrombosis.
    Zahra S; Anderson JA; Stirling D; Ludlam CA
    Br J Haematol; 2011 Mar; 152(6):688-700. PubMed ID: 21303355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Membrane microparticles in VTE and cancer.
    Key NS; Chantrathammachart P; Moody PW; Chang JY
    Thromb Res; 2010 Apr; 125 Suppl 2():S80-3. PubMed ID: 20434013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelial microparticles: a potential contribution to the thrombotic complications of the antiphospholipid syndrome.
    Dignat-George F; Camoin-Jau L; Sabatier F; Arnoux D; Anfosso F; Bardin N; Veit V; Combes V; Gentile S; Moal V; Sanmarco M; Sampol J
    Thromb Haemost; 2004 Apr; 91(4):667-73. PubMed ID: 15045126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microparticle analysis in disorders of hemostasis and thrombosis.
    Mooberry MJ; Key NS
    Cytometry A; 2016 Feb; 89(2):111-22. PubMed ID: 25704723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microparticles as antigenic targets of antibodies to DNA and nucleosomes in systemic lupus erythematosus.
    Ullal AJ; Reich CF; Clowse M; Criscione-Schreiber LG; Tochacek M; Monestier M; Pisetsky DS
    J Autoimmun; 2011 May; 36(3-4):173-80. PubMed ID: 21376534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microparticles and autophagy: a new frontier in the understanding of atherosclerosis in rheumatoid arthritis.
    Barbati C; Vomero M; Colasanti T; Ceccarelli F; Marcosano M; Miranda F; Novelli L; Pecani A; Perricone C; Spinelli FR; Truglia S; Conti F; Valesini G; Alessandri C
    Immunol Res; 2018 Dec; 66(6):655-662. PubMed ID: 30574665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated plasma levels of procoagulant microparticles are a novel risk factor for thrombosis in patients with myeloproliferative neoplasms.
    Taniguchi Y; Tanaka H; Luis EJ; Sakai K; Kumode T; Sano K; Serizawa K; Rai S; Morita Y; Hanamoto H; Tsubaki K; Nishio K; Matsumura I
    Int J Hematol; 2017 Nov; 106(5):691-703. PubMed ID: 28780601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microparticles as autoadjuvants in the pathogenesis of SLE.
    Pisetsky DS; Lipsky PE
    Nat Rev Rheumatol; 2010 Jun; 6(6):368-72. PubMed ID: 20458331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microparticles in atrial fibrillation: a link between cell activation or apoptosis, tissue remodelling and thrombogenicity.
    Jesel L; Abbas M; Toti F; Cohen A; Arentz T; Morel O
    Int J Cardiol; 2013 Sep; 168(2):660-9. PubMed ID: 23623666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet microparticles and vascular cells interactions: a checkpoint between the haemostatic and thrombotic responses.
    Morel O; Morel N; Freyssinet JM; Toti F
    Platelets; 2008 Feb; 19(1):9-23. PubMed ID: 18231934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microparticles: a critical component in the nexus between inflammation, immunity, and thrombosis.
    Morel O; Morel N; Jesel L; Freyssinet JM; Toti F
    Semin Immunopathol; 2011 Sep; 33(5):469-86. PubMed ID: 21866419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.